Login / Signup

Preneoplastic stromal cells promote BRCA1-mediated breast tumorigenesis.

Kevin NeeDennis MaQuy H NguyenMaren PeinNicholas PervolarakisJacob Insua-RodríguezYanwen GongGrace HernandezHamad AlshetaiwiJustice WilliamsMaha RaufKushal Rajiv DaveKeerti BoyapatiAliza HasnainChristian CalderonAnush MarkaryanRobert EdwardsErin LinRitesh ParajuliPeijie ZhouQing NieSundus F ShalabiMark A LaBargeKai Kessenbrock
Published in: Nature genetics (2023)
Women with germline BRCA1 mutations (BRCA1 +/mut ) have increased risk for hereditary breast cancer. Cancer initiation in BRCA1 +/mut is associated with premalignant changes in breast epithelium; however, the role of the epithelium-associated stromal niche during BRCA1-driven tumor initiation remains unclear. Here we show that the premalignant stromal niche promotes epithelial proliferation and mutant BRCA1-driven tumorigenesis in trans. Using single-cell RNA sequencing analysis of human preneoplastic BRCA1 +/mut and noncarrier breast tissues, we show distinct changes in epithelial homeostasis including increased proliferation and expansion of basal-luminal intermediate progenitor cells. Additionally, BRCA1 +/mut stromal cells show increased expression of pro-proliferative paracrine signals. In particular, we identify pre-cancer-associated fibroblasts (pre-CAFs) that produce protumorigenic factors including matrix metalloproteinase 3 (MMP3), which promotes BRCA1-driven tumorigenesis in vivo. Together, our findings demonstrate that precancerous stroma in BRCA1 +/mut may elevate breast cancer risk through the promotion of epithelial proliferation and an accumulation of luminal progenitor cells with altered differentiation.
Keyphrases
  • breast cancer risk
  • single cell
  • signaling pathway
  • bone marrow
  • poor prognosis
  • endothelial cells
  • oxidative stress
  • long non coding rna
  • dna damage
  • papillary thyroid